Japan Influenza Vaccine Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Influenza Vaccine market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Influenza Vaccine market. Detailed analysis of key players, along with key growth strategies adopted by Influenza Vaccine industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.


    By Player:

    • Novavax

    • CSL

    • AstraZeneca

    • GlaxoSmithKline

    • F Hoffmann-La Roche Ag

    • Abbott

    • Mitsubishi Tanabe Pharma

    • Biocryst Pharmaceuticals

    • Sanofi

    • SK Chemicals


    By Type:

    • Quadrivalent

    • Trivalent

    • High-Dose


    By End-User:

    • Pediatrics

    • Adults


    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Influenza Vaccine Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Influenza Vaccine Market Size and Growth Rate of Quadrivalent from 2014 to 2026

      • 1.3.2 Japan Influenza Vaccine Market Size and Growth Rate of Trivalent from 2014 to 2026

      • 1.3.3 Japan Influenza Vaccine Market Size and Growth Rate of High-Dose from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Influenza Vaccine Market Size and Growth Rate of Pediatrics from 2014 to 2026

      • 1.4.2 Japan Influenza Vaccine Market Size and Growth Rate of Adults from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Influenza Vaccine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Influenza Vaccine by Major Types

      • 3.4.1 Market Size and Growth Rate of Quadrivalent

      • 3.4.2 Market Size and Growth Rate of Trivalent

      • 3.4.3 Market Size and Growth Rate of High-Dose


    4 Segmentation of Influenza Vaccine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Influenza Vaccine by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Influenza Vaccine in Pediatrics

      • 4.4.2 Market Size and Growth Rate of Influenza Vaccine in Adults


    5 Market Analysis by Regions

    • 5.1 Japan Influenza Vaccine Production Analysis by Regions

    • 5.2 Japan Influenza Vaccine Consumption Analysis by Regions


    6 Hokkaido Influenza Vaccine Landscape Analysis

    • 6.1 Hokkaido Influenza Vaccine Landscape Analysis by Major Types

    • 6.2 Hokkaido Influenza Vaccine Landscape Analysis by Major End-Users


    7 Tohoku Influenza Vaccine Landscape Analysis

    • 7.1 Tohoku Influenza Vaccine Landscape Analysis by Major Types

    • 7.2 Tohoku Influenza Vaccine Landscape Analysis by Major End-Users


    8 Kanto Influenza Vaccine Landscape Analysis

    • 8.1 Kanto Influenza Vaccine Landscape Analysis by Major Types

    • 8.2 Kanto Influenza Vaccine Landscape Analysis by Major End-Users


    9 Chubu Influenza Vaccine Landscape Analysis

    • 9.1 Chubu Influenza Vaccine Landscape Analysis by Major Types

    • 9.2 Chubu Influenza Vaccine Landscape Analysis by Major End-Users


    10 Kinki Influenza Vaccine Landscape Analysis

    • 10.1 Kinki Influenza Vaccine Landscape Analysis by Major Types

    • 10.2 Kinki Influenza Vaccine Landscape Analysis by Major End-Users


    11 Chugoku Influenza Vaccine Landscape Analysis

    • 11.1 Chugoku Influenza Vaccine Landscape Analysis by Major Types

    • 11.2 Chugoku Influenza Vaccine Landscape Analysis by Major End-Users


    12 Shikoku Influenza Vaccine Landscape Analysis

    • 12.1 Shikoku Influenza Vaccine Landscape Analysis by Major Types

    • 12.2 Shikoku Influenza Vaccine Landscape Analysis by Major End-Users


    13 Kyushu Influenza Vaccine Landscape Analysis

    • 13.1 Kyushu Influenza Vaccine Landscape Analysis by Major Types

    • 13.2 Kyushu Influenza Vaccine Landscape Analysis by Major End-Users


    14 Major Players Profiles

    • 14.1 Novavax

      • 14.1.1 Novavax Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 CSL

      • 14.2.1 CSL Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 AstraZeneca

      • 14.3.1 AstraZeneca Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 GlaxoSmithKline

      • 14.4.1 GlaxoSmithKline Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 F Hoffmann-La Roche Ag

      • 14.5.1 F Hoffmann-La Roche Ag Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 Abbott

      • 14.6.1 Abbott Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 Mitsubishi Tanabe Pharma

      • 14.7.1 Mitsubishi Tanabe Pharma Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 Biocryst Pharmaceuticals

      • 14.8.1 Biocryst Pharmaceuticals Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

    • 14.9 Sanofi

      • 14.9.1 Sanofi Company Profile and Recent Development

      • 14.9.2 Market Performance

      • 14.9.3 Product and Service Introduction

    • 14.10 SK Chemicals

      • 14.10.1 SK Chemicals Company Profile and Recent Development

      • 14.10.2 Market Performance

      • 14.10.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 102 Figures and 123 Tables)

     

    • Figure Japan Influenza Vaccine Market Size and Growth Rate of Quadrivalent from 2014 to 2026

    • Figure Japan Influenza Vaccine Market Size and Growth Rate of Trivalent from 2014 to 2026

    • Figure Japan Influenza Vaccine Market Size and Growth Rate of High-Dose from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Influenza Vaccine Market Size and Growth Rate of Pediatrics from 2014 to 2026

    • Figure Japan Influenza Vaccine Market Size and Growth Rate of Adults from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Influenza Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Influenza Vaccine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Influenza Vaccine

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Influenza Vaccine by Different Types from 2014 to 2026

    • Table Consumption Share of Influenza Vaccine by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Quadrivalent

    • Figure Market Size and Growth Rate of Trivalent

    • Figure Market Size and Growth Rate of High-Dose

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Influenza Vaccine by Different End-Users from 2014 to 2026

    • Table Consumption Share of Influenza Vaccine by Different End-Users from 2014 to 2026

    • Figure Japan Influenza Vaccine Market Size and Growth Rate of Pediatrics from 2014 to 2026

    • Figure Japan Influenza Vaccine Market Size and Growth Rate of Adults from 2014 to 2026

    • Table Japan Influenza Vaccine Production by Regions

    • Table Japan Influenza Vaccine Production Share by Regions

    • Figure Japan Influenza Vaccine Production Share by Regions in 2014

    • Figure Japan Influenza Vaccine Production Share by Regions in 2018

    • Figure Japan Influenza Vaccine Production Share by Regions in 2026

    • Table Japan Influenza Vaccine Consumption by Regions

    • Table Japan Influenza Vaccine Consumption Share by Regions

    • Figure Japan Influenza Vaccine Consumption Share by Regions in 2014

    • Figure Japan Influenza Vaccine Consumption Share by Regions in 2018

    • Figure Japan Influenza Vaccine Consumption Share by Regions in 2026

    • Table Hokkaido Influenza Vaccine Consumption by Types from 2014 to 2026

    • Table Hokkaido Influenza Vaccine Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Influenza Vaccine Consumption Share by Types in 2014

    • Figure Hokkaido Influenza Vaccine Consumption Share by Types in 2018

    • Figure Hokkaido Influenza Vaccine Consumption Share by Types in 2026

    • Table Hokkaido Influenza Vaccine Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Influenza Vaccine Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Influenza Vaccine Consumption Share by End-Users in 2014

    • Figure Hokkaido Influenza Vaccine Consumption Share by End-Users in 2018

    • Figure Hokkaido Influenza Vaccine Consumption Share by End-Users in 2026

    • Table Tohoku Influenza Vaccine Consumption by Types from 2014 to 2026

    • Table Tohoku Influenza Vaccine Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Influenza Vaccine Consumption Share by Types in 2014

    • Figure Tohoku Influenza Vaccine Consumption Share by Types in 2018

    • Figure Tohoku Influenza Vaccine Consumption Share by Types in 2026

    • Table Tohoku Influenza Vaccine Consumption by End-Users from 2014 to 2026

    • Table Tohoku Influenza Vaccine Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Influenza Vaccine Consumption Share by End-Users in 2014

    • Figure Tohoku Influenza Vaccine Consumption Share by End-Users in 2018

    • Figure Tohoku Influenza Vaccine Consumption Share by End-Users in 2026

    • Table Kanto Influenza Vaccine Consumption by Types from 2014 to 2026

    • Table Kanto Influenza Vaccine Consumption Share by Types from 2014 to 2026

    • Figure Kanto Influenza Vaccine Consumption Share by Types in 2014

    • Figure Kanto Influenza Vaccine Consumption Share by Types in 2018

    • Figure Kanto Influenza Vaccine Consumption Share by Types in 2026

    • Table Kanto Influenza Vaccine Consumption by End-Users from 2014 to 2026

    • Table Kanto Influenza Vaccine Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Influenza Vaccine Consumption Share by End-Users in 2014

    • Figure Kanto Influenza Vaccine Consumption Share by End-Users in 2018

    • Figure Kanto Influenza Vaccine Consumption Share by End-Users in 2026

    • Table Chubu Influenza Vaccine Consumption by Types from 2014 to 2026

    • Table Chubu Influenza Vaccine Consumption Share by Types from 2014 to 2026

    • Figure Chubu Influenza Vaccine Consumption Share by Types in 2014

    • Figure Chubu Influenza Vaccine Consumption Share by Types in 2018

    • Figure Chubu Influenza Vaccine Consumption Share by Types in 2026

    • Table Chubu Influenza Vaccine Consumption by End-Users from 2014 to 2026

    • Table Chubu Influenza Vaccine Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Influenza Vaccine Consumption Share by End-Users in 2014

    • Figure Chubu Influenza Vaccine Consumption Share by End-Users in 2018

    • Figure Chubu Influenza Vaccine Consumption Share by End-Users in 2026

    • Table Kinki Influenza Vaccine Consumption by Types from 2014 to 2026

    • Table Kinki Influenza Vaccine Consumption Share by Types from 2014 to 2026

    • Figure Kinki Influenza Vaccine Consumption Share by Types in 2014

    • Figure Kinki Influenza Vaccine Consumption Share by Types in 2018

    • Figure Kinki Influenza Vaccine Consumption Share by Types in 2026

    • Table Kinki Influenza Vaccine Consumption by End-Users from 2014 to 2026

    • Table Kinki Influenza Vaccine Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Influenza Vaccine Consumption Share by End-Users in 2014

    • Figure Kinki Influenza Vaccine Consumption Share by End-Users in 2018

    • Figure Kinki Influenza Vaccine Consumption Share by End-Users in 2026

    • Table Chugoku Influenza Vaccine Consumption by Types from 2014 to 2026

    • Table Chugoku Influenza Vaccine Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Influenza Vaccine Consumption Share by Types in 2014

    • Figure Chugoku Influenza Vaccine Consumption Share by Types in 2018

    • Figure Chugoku Influenza Vaccine Consumption Share by Types in 2026

    • Table Chugoku Influenza Vaccine Consumption by End-Users from 2014 to 2026

    • Table Chugoku Influenza Vaccine Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Influenza Vaccine Consumption Share by End-Users in 2014

    • Figure Chugoku Influenza Vaccine Consumption Share by End-Users in 2018

    • Figure Chugoku Influenza Vaccine Consumption Share by End-Users in 2026

    • Table Shikoku Influenza Vaccine Consumption by Types from 2014 to 2026

    • Table Shikoku Influenza Vaccine Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Influenza Vaccine Consumption Share by Types in 2014

    • Figure Shikoku Influenza Vaccine Consumption Share by Types in 2018

    • Figure Shikoku Influenza Vaccine Consumption Share by Types in 2026

    • Table Shikoku Influenza Vaccine Consumption by End-Users from 2014 to 2026

    • Table Shikoku Influenza Vaccine Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Influenza Vaccine Consumption Share by End-Users in 2014

    • Figure Shikoku Influenza Vaccine Consumption Share by End-Users in 2018

    • Figure Shikoku Influenza Vaccine Consumption Share by End-Users in 2026

    • Table Kyushu Influenza Vaccine Consumption by Types from 2014 to 2026

    • Table Kyushu Influenza Vaccine Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Influenza Vaccine Consumption Share by Types in 2014

    • Figure Kyushu Influenza Vaccine Consumption Share by Types in 2018

    • Figure Kyushu Influenza Vaccine Consumption Share by Types in 2026

    • Table Kyushu Influenza Vaccine Consumption by End-Users from 2014 to 2026

    • Table Kyushu Influenza Vaccine Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Influenza Vaccine Consumption Share by End-Users in 2014

    • Figure Kyushu Influenza Vaccine Consumption Share by End-Users in 2018

    • Figure Kyushu Influenza Vaccine Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Novavax

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novavax

    • Figure Sales and Growth Rate Analysis of Novavax

    • Figure Revenue and Market Share Analysis of Novavax

    • Table Product and Service Introduction of Novavax

    • Table Company Profile and Development Status of CSL

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL

    • Figure Sales and Growth Rate Analysis of CSL

    • Figure Revenue and Market Share Analysis of CSL

    • Table Product and Service Introduction of CSL

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of F Hoffmann-La Roche Ag

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche Ag

    • Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche Ag

    • Figure Revenue and Market Share Analysis of F Hoffmann-La Roche Ag

    • Table Product and Service Introduction of F Hoffmann-La Roche Ag

    • Table Company Profile and Development Status of Abbott

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott

    • Figure Sales and Growth Rate Analysis of Abbott

    • Figure Revenue and Market Share Analysis of Abbott

    • Table Product and Service Introduction of Abbott

    • Table Company Profile and Development Status of Mitsubishi Tanabe Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mitsubishi Tanabe Pharma

    • Figure Sales and Growth Rate Analysis of Mitsubishi Tanabe Pharma

    • Figure Revenue and Market Share Analysis of Mitsubishi Tanabe Pharma

    • Table Product and Service Introduction of Mitsubishi Tanabe Pharma

    • Table Company Profile and Development Status of Biocryst Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocryst Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Biocryst Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Biocryst Pharmaceuticals

    • Table Product and Service Introduction of Biocryst Pharmaceuticals

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of SK Chemicals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SK Chemicals

    • Figure Sales and Growth Rate Analysis of SK Chemicals

    • Figure Revenue and Market Share Analysis of SK Chemicals

    • Table Product and Service Introduction of SK Chemicals

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.